Cargando…
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
Chronic hepatitis B virus (HBV) infection is prevalent, deadly, and seldom cured due to the persistence of viral episomal DNA (cccDNA) in infected cells. Newly developed genome engineering tools may offer the ability to directly cleave viral DNA, thereby promoting viral clearance. Here, we show that...
Autores principales: | Ramanan, Vyas, Shlomai, Amir, Cox, David B.T., Schwartz, Robert E., Michailidis, Eleftherios, Bhatta, Ankit, Scott, David A., Zhang, Feng, Rice, Charles M., Bhatia, Sangeeta N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649911/ https://www.ncbi.nlm.nih.gov/pubmed/26035283 http://dx.doi.org/10.1038/srep10833 |
Ejemplares similares
-
A robust cell culture system supporting the complete life cycle of hepatitis B virus
por: Michailidis, Eleftherios, et al.
Publicado: (2017) -
Nucleosomes inhibit target cleavage by CRISPR-Cas9 in vivo
por: Yarrington, Robert M., et al.
Publicado: (2018) -
Programmable RNA recognition and cleavage by CRISPR/Cas9
por: O’Connell, Mitchell R., et al.
Publicado: (2014) -
A cleavage-based surrogate reporter for the evaluation of CRISPR–Cas9 cleavage efficiency
por: Jung, Soo Bin, et al.
Publicado: (2021) -
Abrogation of PRRSV infectivity by CRISPR-Cas13b-mediated viral RNA cleavage in mammalian cells
por: Cui, Jin, et al.
Publicado: (2020)